Goldman Sachs upgraded Thoratec (NASDAQ: THOR) from Neutral to Buy with a price target of $46.00 (from $40.00).

Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE